Search details
1.
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.
Cancer
; 130(12): 2191-2204, 2024 Jun 15.
Article
in English
| MEDLINE | ID: mdl-38376917
2.
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer.
Prostate
; 83(6): 524-533, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36604824
3.
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
BMC Cancer
; 23(1): 265, 2023 Mar 23.
Article
in English
| MEDLINE | ID: mdl-36949413
4.
Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
Prostate
; 82(2): 182-192, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34672379
5.
A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis.
Prostate
; 82(13): 1293-1303, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35790016
6.
Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia.
J Oncol Pharm Pract
; 28(1): 17-23, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33323023
7.
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide.
Prostate
; 79(11): 1347-1359, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31228231
8.
IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling.
Prostate
; 77(8): 866-877, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28240376
9.
Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer.
Cancer Res Commun
; 2024 Jun 10.
Article
in English
| MEDLINE | ID: mdl-38856749
10.
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.
Prostate Cancer Prostatic Dis
; 2024 Feb 22.
Article
in English
| MEDLINE | ID: mdl-38383885
11.
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
JCO Precis Oncol
; 8: e2300567, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38579192
12.
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells.
Mol Cancer Ther
; 22(3): 381-392, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36805730
13.
A Novel Role of Prostate-Specific Membrane Antigen in Telomere Stability in Prostate Cancer Cells.
Mol Cancer Res
; 21(11): 1176-1185, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37477641
14.
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
PLoS One
; 18(9): e0291315, 2023.
Article
in English
| MEDLINE | ID: mdl-37713401
15.
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.
Res Sq
; 2023 Aug 10.
Article
in English
| MEDLINE | ID: mdl-37609284
16.
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.
JAMA Netw Open
; 6(9): e2334208, 2023 09 05.
Article
in English
| MEDLINE | ID: mdl-37721753
17.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
JAMA Oncol
; 9(10): 1390-1400, 2023 Oct 01.
Article
in English
| MEDLINE | ID: mdl-37589970
18.
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
JAMA Oncol
; 9(1): 128-134, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36326731
19.
Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
medRxiv
; 2023 Mar 10.
Article
in English
| MEDLINE | ID: mdl-37205429
20.
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.
Transl Oncol
; 34: 101709, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37302348